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Homeostasis in continually renewing tissues is maintained by 
a tightly regulated balance between cell proliferation, cell 
differentiation, and cell death. Until recently, proliferation 
was thought to be the primary point of control in the regula-
tion of normal tissue kinetic homeostasis and as such has been 
the major focus of both understanding the etiology of disease 
and developing therapeutic strategies. Now, physiologic cell 
death, known as apoptosis (a-pop-to'sls, a-po-to'sls [Thomas 
CL (ed.): Taber's Cyclopedic Medical Dictionary. F.A. 
HISTORICAL BACKGROUND AND DEFINITION 
OF APOPTOSIS 
Two distinct forms of cell death, necrosis and apoptosis, are recog-
nized (reviewed in [1 J). Despite the early recognition of pro-
grammed cell death as a normal physiologic event in development, 
cell death historically has been considered to be primarily a patho-
logic process. Gliicksmann [2] indicated the biologic significance of 
more than 50 individual instances of programmed cell death in 
embryogenesis but Kerr [3] was the first to emphasize that naturally 
occurring physiologic single-cell death exists also in adult tissues 
and to show in electron microscopy studies [4] that this form of cell 
death is clearly distinct from pathological cell death (necrosis). Al-
though initially called "shrinkage necrosis," the term "apoptosis," 
from the Greek for "falling off" as in leaves or petals, was coined by 
Kerr el al [4] to indicate the orderly pattern of cytoplasmic and 
nuclear changes that leads to self-destruction of single cells and 
deletion from the tissues without injury to neighboring cells. 
Whether the term programmed cell death, applied in a develop-
mental context, should be used synonymously with apoptosis is still 
under debate. They share many morphologic characteristics, and are 
more similar to each other than either is to necrosis, yet some differ-
ences between programmed cell death and apoptosis have been de-
scribed. Because programmed cell death during development may 
take a slightly different form than apoptosis in adult tissues some 
consider it simply to be a s?,ecial developmental form of apoptotic 
cell death (reviewed in [5 J) that is initiated by as yet unknown 
spatially and temporally defined cues. However, both programmed 
cell death and apoptosis are clearly controlled cell death, in the sense 
that they each follow an intrinsic gene-directed pathway, initiated 
by physiologic or environmental stimuli, whereas there is no evi-
dence that necrosis is programmed. Terminal differentiation is an-
other example of cell death that may be considered a specialized 
form of the apoptotic program that has evolved to serve tissue-spe-
cific functions, perhaps best exemplified by the terminal differen-
tiation of the erythrocyte and the epidermal keratinocyte. 
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Davis, Co., Philadelphia, 1989)] has gained scientific recog-
nition as an active regulatory mechanism, complementary, 
but functionally opposite, to proliferation with important 
roles in shaping and maintaining tissue size and prevention of 
disease. In this review we will describe the concept of apop-
tosis and discuss possible molecular mechanisms of its regula-
tion that may have implications for skin biology. ] ItlVest 
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APOPTOSIS IN EPIDERMIS AND OTHER TISSUES 
Apoptosis is a feature of many diverse biologic processes but in each 
case the common function of elimination of unnecessary, damaged , 
or harmful cells is served. In development programmed cell death 
removes cells during remodeling of a number of organs undergoing 
morphogenesis including the limb bud, nervous system, and the 
metanephros during mesenchymal-epithelial transition [1,2,6]. 
Tissue regression by apoptosis following hormone stimulation or 
deprivation occurs in a large number of hormone-sensitive tissues 
such as the prostate after androgen withdrawal [1,7] and in the 
atretic ovarian follicle [1] . Apoptosis contributes to the generation 
of diversity in the immune system by functioning in clonal selection 
of immature thymocytes, B-cells, and antigen-primed peripheral T 
cells and also protects us from autoimmunity by deletion of self-
reactive cells. The mode of target cell killing by cytotoxic T lym-
phocytes in cell-mediated immune reactions is by apoptosis ([8] and 
references therein). In addition to the lymphatic tissues, other con-
tinually renewing tissues, especially epithelia such as those of the 
gastrointestinal tract, the liver, and the epidermis, have apoptotic 
cells within their normal cell populations. Apoptosis is thought to 
playa major role in regression of neoflasms, either spontaneous or 
induced by cytotoxic drugs or X-rays 1]. In the skin, cells dying by 
apoptosis have been found in Bowen's disease, squamous cell carci-
noma, and malignant melanoma and cell death likely accounts for 
the slow growth rate of basal cell carcinoma, despite the high mi-
totic rate. Also in the skin an increase in apoptotic cells has been 
described in the epidermis in various lichenoid diseases such as li-
chen planus, in graft-versus-host disease, fixed drug eruptions, dur-
ing regression of warts, in response to ultraviolet radiation (forma-
tion of "sunburn cells"), and in the hair follicle during catagen 
phase of the hair cycle (reviewed in [9]). 
MORPHOLOGY OF APOPTOTIC CELLS 
In a scientific discipline dominated by the techniques of molecular 
biology, it is telling that the original morphologic criteria are still 
heavily relied upon in the recognition and characterization of this 
newly appreciated process. Even though biochemical and molecular 
correlates, such as synthesis and activity of tissue transglutaminase 
[10] and a Ca++ /Mg++ -dependent endonuclease [11], are now be-
coming available, the investigator must look for progressive 
changes in cell structure (Fig I) evident at the light- or electron-mi-
croscopic levels, to identify an apoptotic cell. 
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Figure 1. The first morphologic indications of apoptosis are cell shrinkage and loss of cell-cell contacts, accompanied by condensation of chromatin at t~e 
margin of the nuclear membrane 1. The cytoskeletal structure collapses and the cell often becomes rounded and detached from the pencellular matrix, 
although the plasma membrane remains intact and the apoptotic cell is impermeable to dyes such as trypan blue. In histologic sections, cells at this stage of 
apoptosis appear shrunken, with small amounts of eosinophilic cytoplasm and marginally condensed basophilic nuclei . Nuclear fragmentation (karyorrheXIS) 
next occurs, followed by fragmentation of the entire cell without rupture oflysosomes or mitochondria 2. Cellular fragmentation results in the formatIOn of 
apoptotic bodies, small membrane-bound vesicles containing nuclearfragments, and other cellular constituents, .some of which are too small to be visualized ~t 
the light microscopic level. Apoptotlc bodies are phagocytosed by neighbOring cells or macrophages Without eVidence of l11f1ammatlOn 3. In contrast, necr?sls 
is characterized by early cel l swelling, loss of integrity of mitochondrial and plasma membranes and rupture of Iysosomes leading to gross tissue inflammation 
[1] . The duration of apoptosis from initial cell shrinkage through removal of apoptotic bodies is short, requiring as little as 1- 3 h in lymphocytes [11], but up to 
48 - 72 h in epidermal keratll10cytes [14). Illustratlon and descnptlOn adapted from [1]. 
In the skin, cells that conform to this pattern of morphologic 
changes and are now recognized as apoptotic have been indepen-
dently described and named in the field of dermatopathology (re-
viewed in [9]) . The term "Civatte bodies" was applied to the shrun-
ken eosinophilic basal epidermal cells characteristic of lichen 
planus. Civatte bodies, as well as the abnormal cells of a number of 
other disorders, have also been referred to as "dyskeratotic" usually 
implying disordered or premature keratinization. The reader must 
be wary because "dyskeratotic cell" is a descriptive term and should 
not necessarily imply a specific cellular process. In fact, some, but 
not all, cells described in the literature as dyskeratotic are actually 
apoptotic [12J. Another descriptive term applied to keratinocytes 
undergoing apoptosis is "dark cell" because of the heavy staining 
properties of the condensed cytoplasm and nucleus ([13J and refer-
ences therein). The "sunburn cell," used as an example of apoptosis 
by Kerr in his landmark paper [4J, is a basal or suprabasal keratino-
cyte described 'as shrunken, with a densely stained glassy cytoplasm 
and hyperchromatic condensed pyknotic nucleus that appears fol-
lowing ultraviolet irradiation [14J. Apoptotic bodies have been 
identified in the epidermis and also within phagocytosing neigh-
boring keratinocytes. Due to the abundance of tonofilaments in the 
keratinocyte, some apoptotic bodies are not easily phagocytosed and 
apparentl y become the basement membrane - surrounded" keratin 
bodies" or "colloid bodies" that have been described in the upper 
portion of the dermis [15J. 
CONTROL OF APOPTOSIS 
Attention on the regulation of apoptosis has been increasing because 
of the important biologic implications of a gene-directed cell death 
process. Although most likely a general phenomenon, apoptosis has 
been studied predominantly in trophic-dependent tissues such as 
those of the hematopoietic system, the prostate and liver, and the 
developing nervous system, perhaps because in these tissues cell 
death occurs naturally at a high rate and because it is readily induci-
ble in response to changes in trophic factors or other extracellular 
stimuli. Despite the rapidly increasing data in this field , the molecu-
lar mechanisms of apoptosis, the nature of the cell signaling, and the 
intrinsic factors that promote and regulate cell death, are still largely 
unknown. However, based on the constant morphologic changes 
(described above) and several common biochemical and molecular 
characteristics of dying cells, certain rules appear to govern the 
process of apoptosis. 
Apoptosis Is an Active, Genetically Controlled Process 
Apoptosis is an energy-dependent process, requiring adenosine tri-
phosphate synthesis from intact mitochondria [16]. Studies using 
inhibitors, actinomycin D, and cycloheximide, have demonstrated 
that in most cases, not always [17J, apoptosis will not proceed in the 
absence of RNA and protein synthesis, supporting the argument 
that apoptosis is an active, genetically controlled process and sug-
gesting that the cell carries an intrinsic capacity of self destruction. 
Perhaps the best evidence that apoptosis is of genetic origin comes 
from the study of programmed cell death during development of 
the nematode Caenorhabditis elegans (reviewed in [18]), which also 
has provided further insight into the cellular, molecular, and ge-
netic details of cell death, in general. The initiation, execution, and 
completion of the cell death program is regulated by a set of genes, 
some of which already have been identified by genetic analysis of C. 
e1egal1s mutants. This simple organism is bui lt of 959 somatic cells 
that remain to function in the adult whereas 131 of 1090 cells 
originally produced by the division of the fertilized egg arc geneti-
cally programmed to die at specific times and locations in the devel-
oping worm. It appears that in the nematode the regulation of cell 
death is not simply a matter of turning on the death program. 
Rather, the major control is to prevent cell death. Cell death is 
suppressed in the presence of a functional ced-9 gene [19J. Loss of 
ced-9 function by mutation initiates the cell death program, the 
execution of which requires cell-type-specific activation of the 
wild-type ced-3 and ced-4 genes, whose gene products have not 
been fully characterized. The ced-3 and ced-4 mutants escape death 
and do not proliferate, but differentiate according to their normal 
lineage program indicating that they are beyond division and have 
entered the differentiation/cell death pathway. Programmed cell 
death in C. elegal1s culminates in the genetically controlled recogni-
tion and engulfment of the dying cell by its neighbor and digestion 
of its genome by the nuc-l-encoded DNA endonuclease. 
The sequence of events and morphologic pattern of the dying C. 
e1egans cell in many respects resembles apoptosis in mammals and 
suggests evolutionary conservation of the cell-death program. In 
fact, transfection [20-22J and transgenic mice studies [23J estab-
lished that acquisition of constitutive expression of a protoonco-
gene, bcl-2, that when altered correlates with human follicular B-
cell lymphoma, promotes survival of affected cells. Significantly, 
expression of the human bcl-2 gene can inhibit programmed cell 
death in transfected C. e1ega/'ls suggesting functional analogy be-
tween C. e1egal1s ced-9 and human bcl-2 genes and implying that the 
molecular mechanism of cell death controlled by bcl-2 in humans 
and by ced-9 in nematodes might be the same [24J. 
The Intrinsic Program of Apoptosis Can Be Enhanced or 
Inhibited by Extrinsic Stimuli We now know many factors 
. that can initiate or suppress the self-destruction 'program under ex-
perimental conditions (extensively reviewed in [25]). A large num-
ber of these are growth factors and hormones, which are also known 
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to affect cell proliferation. These factors can either stimulate apop-
tosis, as in the case of immature thymocytes treated with glucocorti-
coids [11]. cytolytic cytokines such as tumor necrosis factor [26]' and 
in primary cultures of uterine epithelia l cells treated with trans-
forming growth factor beta (TGFfJ) [27] or they can inhibit apopto-
sis, as does nerve growth factor when added to growing neural cells 
[28] or granulocyte-macrophage colony-stimulating factor added to 
hematopoietic progenitor cells [29]. Another class of factors that 
affect apoptosis are agents that modulate intracellular Ca++ or cyclic 
adenosine monophosphate such as Ca++ ionophores that induce 
apoptosis in lymphoid cells [30] or 12-0-tetradecanoylphorbol-13-
acetate that inhibits apoptosis probably through the protein kinase 
C pathway [31]. Pharmaceuticals used in cancer chemotherapy and 
physical agents such as ultraviolet light [32,33] or y- and X- irradia-
tion [34] used in radiation therapy arrest cell proliferation but also 
induce apoptosis possibly by interruption of chromatin structure, as 
inhibitors of topoisomerase II also can do [35], or by affecting the 
integrity of chromosomes and introduction of radiation-induced 
double-stranded DNA breaks [25,35]. Cell-surface proteins also ap-
pear to mediate the induction of apoptosis. This is exemplified by 
the APO-1/Fas antigen belonging to the tumor necrosis factor fam-
ily of receptors. Apoptosis can be artificially triggered in T- and 
B-cell tumor lines by anti-APO-l/anti-Fas monoclonal antibody. 
[36]. Finally, natural cell death during morphogenesis must be initi-
ated by factor(s), in many instances unidentified, whose activation 
appears to be written into the developmental program. These fac-
tors are likely among morpho gens and hormones already known to 
function in development. For example, Miillerian-inhibiting sub-
stance, a member of the TGFfJ gene family, initiates regression of 
the Miillerian duct in males [37] . Similarly, retinoic acid likely plays 
an important role in programmed cell death through one of its 
specific receptors, RARfJ. RARfJ is expressed in tissues destined to 
die during mouse embryogenesis [38] and it has been suggested that 
the teratogenic effects of retinoids are due to expanded cell death in 
tissues that normally undergo limited cell death [39]. 
Components of the Apoptotic Pathway Function in Other 
Cellular Processes One can induce apoptosis and determine its 
outcome - the death of the cell - yet there is very little detailed 
understanding of the process. One common observation for most of 
the factors known to initiate apoptosis is that they alter the gene-ex-
pression pattern or activity of constitutively synthesized proteins in 
the cell promoted to die and these proteins may function in the 
apoptotic pathway as well as in other cellular processes. For exam-
ple, UV radiation is known to introduce nicks in DNA that then 
activate a DNA repair enzyme, poly(ADP-ribose) polymerase. The 
process of extensive DNA repair by poly(ADP-ribose)polymerase, 
in turn, can deplete cellular nicotinamide adenine dinucleotide 
(NAD+) and consequently adenosine triphosphate and finally the 
loss of energy may lead to cell death [25,35]. 
One of the strongest correlations of a specific biochemical activ-
ity with apoptosis is the activation or increased synthesis of a Ca++ / 
Mg++ -dependent endonuclease. Endonuclease activity has been 
shown to be associated with induction of apoptosis in lymphoid 
cells [11,40] and also in keratinocytes [41]. Activity of this enzyme 
results in DNA fragmentation into nucleosome-sized segments that 
can be visualized after electrophoresis as a ladder of fragments that 
differ in size by 180-200 basepairs. The DNA ladder is general ly 
accepted to be a hallmark [1 ,40] as well as a cause of apoptosis in 
some cell types such as lymphocytes [17,40]. Endonuclease activity 
may function simply as a "cleaning-up" mechanism [18,42] because 
its loss by mutation does not prevent programmed cell death. In a 
number of other cases of programmed cel l death during develop-
ment internucleosomal DNA degradation does not occur [5] or it 
may be difficult to discern against the background of non-apoptotic 
cells [5,43]. Whether the endonuclease is a cause or consequence is 
still in question and complicated further by identification of two 
different types of endonuclease associated with apoptosis in mam-
malian cells: DNase I -like [42] and Ca++ - independent DNase II 
[30]. 
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It appears that Ca++ is an important regulator of apoptosis. The 
activity and synthesis of another Ca++-dependent enzyme, type II 
(tissue) transglutaminase, normally present in many cell types, is 
induced in apoptotic cells. Although high levels of type II transglu-
taminase do not necessarily lead to apoptosis, its cross-linking activ-
ity causes irreversible structural changes such as formation of the 
apoptotic envelope; a highly insoluble rigid structure that prevents 
leakage of cytoplasmic contents and development of an inflamma-
tory response. Quantitation of these envelopes, the apoptotic index, 
is a measure of the rate of apoptosis. Transglutaminase may also be 
involved in membrane remodeling during apoptosis [10]. This and 
other cell-surface modifications such as expression of the sulfated 
glycoprotein encoded by the testosterone-repressed prostate mes-
sage 2 gene and the cell-surface receptor for vitronectin appear to 
function in recognition of apoptotic cells during phagocytosis 
[37,43]. 
Perhaps most important is that the patterns of expression of the 
same protooncogenes/anti-oncogenes that control the cell cycle 
and proliferation are changed, suggesting that they play some regu-
latory role in the cascade of events during cell death. In regressing 
rat prostate glands, androgen withdrawal results in the sequential 
induction of the protooncogenes c-fos, c-myc, and the heat shock 
protein, hsp70, gene transcripts [44]. Depletion of growth factor 
induces c-fos and c-jun protooncogenes in dying lymphoid cell lines 
[45]. The intracellular level of p53, a tumor suppressor gene, in-
creases dramatically in response to a variety of DNA damaging 
agents, including in human skin after exposure to ultraviolet radia-
tion [46]. These correlations allow for one more general statement; 
the cell cycle and apoptosis share a common regulatory pathway 
that diverges at some point and the cell either divides or dies. 
MODELS OF APOPTOSIS 
Is the regulation of apoptosis in mammalian cells operating to pre-
vent cell death and assure cell survival or to induce cell death and 
impose self destruction? In other words, from the practical point of 
view, to interfere with and study cell death experimentally, should 
we look for inhibitors of inducers or rather for activators of repres-
sors of apoptosis? Arguments supporting both views can be found in 
the literature. For example, Raff in his review article [47] provides a 
variety of convincing evidence that the cell, once produced through 
cell division, would die in the absence of continuous suppression of 
the death program by survival signa ling factors delivered by other 
cells. Dependence of hematopoietic cells on hormones and cyto-
kines for survival and the developing nervous system on nerve 
growth factor are good examples of such a social control of cell 
survival. Again, genes such as bcl-2 in human cells or ced-9 in C. 
elegans appear to have an important role in prevention of apoptosis. 
In the presence of survival factors encoded by these genes a normal 
ce ll could proliferate and in their absence the cell would either 
differentiate or turn on the death pathway. In support of this model, 
bcl-2 expression has been localized to long lived cells, cells known 
to eventually undergo apoptosis, tissues with high cell turnover and 
in adult skin in the proliferating cell layer, suggesting suppression of 
the apoptotic program in these cells by bcl-2 [48]. The advantage of 
a mechanism that operates by suppression of a constitutively active 
cell death program by tissue-specific survival factors would be, ac-
cording to Raff [47], to provide a simple way to eliminate overpro-
duced, no longer needed, misplaced, or mutated cells (perhaps un-
able to recognize or respond to survival factors) and prevent 
metastasis. Conversely, the ability to synthesize cell-specific recep-
tors would assure continued response to survival factor. 
A different mechanism of "unbalanced signaling" is proposed by 
McConkey (49] to account for apoptosis in thymocytes induced by 
Ca++ ionophores, glucocorticoids, or tumor necrosis factor. In this 
model the extracellular inducers would activate the cell death pro-
gram by a sustained increase of intracellular Ca++ and cyclic adeno-
sine monophosphate, the second messengers of signal-transduction 
pathways, and subsequent activation of the factors, such as the 
Ca++ /Mg++ -dependent endonuclease, that execute cell death. Ele-
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vated levels of Ca++ or cyclic adenosine monophosphate induce the 
endonuclease-dependent apoptosis pathway but they also are 
known inducers of cell proliferation in thymocytes. Whether the 
cell dies or proliferates would depend on the presence or absence of 
an appropriate second signal. For example, that could explain why a 
Ca++ signal present concomitantly with activation of protein kinase 
C inhibits DNA fragmentation . Thus, apoptosis either is triggered, 
as in the first model, by lack of survival factors, which can be the 
same growth factors and hormones that also regulate cell division, 
or by inducers that control proliferation or apoptosis, depending on 
the balance of other factors, as in the second model. 
Importantly, the two models merge at the cell cycle. In fact stud-
ies with chemotherapeutic agents show that the cell must be in cycle 
to enter the apoptotic pathway [44]. This is supported by the finding 
that hormone-regulated apoptosis in prostate cells coincides with 
cell-cycle activities. Apoptosis induced by androgen depletion is 
preceded by expression of molecular markers of proliferation, in-
cluding proliferating cell nuclear antigen expression and BrdUrd 
incorporation into DNA, suggesting that cells re-enter the cell cycle 
before progressing to DNA degradation. These dying cells also 
express the f53 tumor suppressor gene that inhibits S-phase pro-
gression [44 . 
How then can genes that control cell-cycle progression deter-
mine two opposing cellular activities, cell division and cell death? 
Evidence from prostate epithelia studies imply that apoptosis and 
mitosis occur through identical early molecular pathways but ab-
normal re-entry of the differentiated cell into S-phase and then 
inhibition by p53 results in activation of the apoptotic pathway 
because the differentiated cell has lost its capacity to divide. p53 
appears to serve as a guard of the genome in response to stress [46]. If 
anything goes wrong in the cell cycle or DNA becomes intensively 
damaged beyond repair, p53 will abrogate the cell cycle and the 
abnormal cell wi ll enter the death pathway. In the absence of p53 
the abnormal cell wi ll survive and eventually become tumorigenic. 
This model is supported by transfection studies with c-myc [50] and 
with p53 [51]. 
Upregulated c-myc expression in growth-arrested cells leads to 
cell death by apoptosis [50] perhaps because the block of the cell 
cycle together. with lack of appropriate differentiation signals, sup-
pression of differentiation by c-myc, or imbalance of regulatory 
proteins results in the activation of the program of apoptosis. Like-
wise, overexpression of wild tytJe ~53 in already-transformed cells 
results in induction of apoptosis l51 J. A function of p53 in activation 
of apoptosis is consistent with induction of p53 in damaged cells and 
the fact that cancer cells often have mutated p53. In 58% of invasive 
SCC p53 was shown to be a target for ultraviolet-induced DNA 
damage [52] and p53 is a target for E6 protein in cells immortalized 
by human papillomavirus 16 [53]. 
Is there any particular point of the cell cycle at which entry into 
apoptosis is controlled? There is evidence that apoptosis can be 
promoted at any point of the cell cycle except perhaps mitosis but 
that the sensitivity of a given point of the cell cycle to induction of 
apoptosis is dependent on the nature of the inducing agent and the 
physiologic condition of the cell [25,50]. Ultraviolet induction of 
the sunburn cell in the epidermis is related to the cell cycle, occur-
ring predominantly in S-phase cells [33]. Also ov.erexpression of 
transfected c-myc wil l induce apoptosis in cells arrested in Go by 
serum deprivation, G1 by interferon, late G 1 by isoleucine depriva-
tion S-phase by an excess of thymidine, and S/G2 by inhibition of 
topoisomerase II [47,50] . 
Apoptosis, then, cou ld be pictured as abrogated cell proliferation 
and specific gene products associated with apoptosis, such as the 
endonuclease, transglutaminase, and vitronectin or modified glyco-
proteins on the cell surface [25,37] would be secondary effects re-
sulting in physical disintegration of the abnormal cell , prevention of 
leakage of cell contents, recognition by phagocytosing cells, and 
deletion from the tissue. Thus specific "death genes" may be COI1-
fined only to factors involved in the process of cell elimination 
rather than the genes that determine the onset of the apoptotic 
program. However, two mRNA syecies unique to dying thymo-
cytes recently have been identified l54] but their roles in thymocyte 
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apoptosis and their expression in other apoptotic cells have not yet 
been established to verify that they are "death genes." 
To summarize, it appears that apoptosis is an intrinsically written 
program that shares a molecular pathway with the normal cell cycle 
and as such is regulated by the same molecular mechanisms that 
control cell growth and proliferation and is sensitive to the same 
environmental factors. Whether the cell divides or dies depends on 
the fine tuning of regulatory proteins and the health of the cell in 
general. Apoptosis is prevented by suppressors such as the bcl-2 gene 
product but cell damage or the onset of a developmental program 
can derepress the death program and the cell is destined to die. The 
inhibition of cell growth appears to be a prerequisite for apoptosis 
and perhaps under physiologic conditions is installed by either 
TGFp or p53. The cell can either die rapidly by apoptosis or slowly 
by terminal differentiation, after serving tissue-specific function. In 
that sense terminal differentiation may be considered a specialized 
form of apoptosis. Tissue specificity and the existence of tissue spe-
cific genes may explain variations in the mode of apoptosis in differ-
ent cell types. 
IMPLICATIONS FOR SKIN BIOLOGY 
For these studies to have bearing on skin biology it must be estab-
lished that apoptosis is an important control point in normal epider-
mal homeostasis, not only an anomaly of certain skin diseases. In 
fact, Budtz [13] makes a strong case for such a role of apoptosis 
through a series of elegant studies of toad skin spanning more than a 
decade. Budtz convincingly demonstrated that the toad epidermis 
has an excessive mitotic rate, that cell deletion by apoptosis removes 
the excess cells, thus sculpturing the epidermal architecture, and 
that the rate of apoptosis is controlled by pituitary hormones. Pitui-
tary ablation studies demonstrated that, like proliferation, there is a 
basal rate of apoptosis that is unaffected by hormonal control. 
Therefore, in amphibian skin apoptosis is a significant factor of the 
epidermal equation, balancing the difference between cell birth and 
cell loss through desquamation. These findings probably can be 
extended to mammalian skin as well because the apoptotic process 
described by Butdz was similar to that described for normal human 
epidermis [15] and recently cells that appear to be apoptotic have 
been localized in normal adult human epidermis [48] and develop-
ing human epidermis" by the terminal deoxynucleotidyl trans-
ferase-mediated dUTP-biotin nick end labeling [43] method. 
Is there evidence that control of epidermal apoptosis conforms to 
the models of control proposed for other cell types? Gradient sepa-
ration of mouse epidermal granular cells from basal cells allowed 
McCall and Cohen [41] to show that DNA fragmentation occurs 
specifically in the differentiating compartment by a Ca++-activated 
endonuclease that is already present, but inactive, in the proliferat-
ing cell compartment. These authors proposed that in epidermis 
there are "death proteins" {such as the endonuclease} and inhibitors 
of these proteins and that the inhibitors have a shorter half-life so 
that when protein synthesis stops the death proteins can act [41]. 
What are these factors/inhibitors in epidermis? We propose that 
some of the same factors that control keratinocyte proliferation and 
differentiation, such as Ca++, retinoic acid, TGFp, and epidermal 
growth factor also may be involved in the initiation and progression 
of apoptosis in the epidermis. The pathway that a keratinocyte takes 
will depend, as in other tissues, on the balance of these factors 
perhaps according to the following model. As cells arise in the basal 
layer by cell division, they express BcI-2 initially and are protected 
from death. BcI-2 is expressed in the basal cell layer, but not supra-
basal cells, of developing human fetal skin" and in the adult epider-
mis [48]. Our studies" showing differential intensities of staining in 
basal cells suggest that the level of BcI-2 may decline in basal cells 
because of dilution through continued cell division or through deg-
radation. Cells destined to die by apoptosis or undergo terminal 
differentiation move up to suprabasal layers {is loss of BcI-2 in-
volved in the signal to move up?}. Suprabasal keratinocytes stop 
_ proliferating possibly in response to downregulation of c-myc or 
• Polakowska RR, Piacentini M, Bartlett R, Goldsmith LA, and Haake 
AR (manuscript submitted). 
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synthesis of TGFp [55 ,56J. TGFp, synthesized in suprabasal cel ls, 
may be a prerequisite for the apoptotic pathway because it is ex-
pressed in cells j ust prior to the onset of apoptosis [37J. Following 
cell-cycle arrest most keratinocytes undergo terminal differentia-
tion, express differentiation-specific genes, and eventually die, 
whereas some immediately die by apoptosis as a result of an intri nsic 
program, imbalance of signali ng factors, or cell damage. 
Is terminal differentiation a case of specialized apoptosis as sug-
gested by some investigators [1 O,16J or are these two processes inde-
pendent? In epidermis cellular and molecular events are shared by 
apoptosis and terminal differentiation . Our preliminary results'" in-
dicate that retinoic acid, 12-0-tetradecanoylphorbol-13-acetate, 
and TGFp, in addition to affecting proliferation and differentiation 
of the epidermis, influence th e number of apoptotic cells and thei r 
positions within the epidermis. Also, an increase in the Ca++ con-
centration induces apoptosis and induces keratinocyte terminal dif-
ferentiation. Ca++-activated endonuclease and transglutaminases 
may function both in keratinocyte apoptosis and terminal differen-
tiation. In epidermis and differentiating cultured keratinocytes type 
I transglutaminase, rather than tissue type II , is the major form of 
the enzyme [57J. It is possible that type I functions in keratinocyte 
apoptosis as well as in terminal differentiation catalyzing the forma-
tion of the apoptotic envelope or analagous keratinocyte cell enve-
lope. The nucleus of keratinocytes in the epidermal granular disin-
tegrates, apparently by endonuclease digestion of chromatin into 
nucleosome size fragments [41 J, as in apoptosis. Specialization in 
terminally differentiating keratinocytes by expression of differen-
tiation-specific genes, such as keratins, loricrin, and filaggrin, 
confers tissue-specific function. Thus, in agreement with Fesus' [58] 
model of molecular events in apoptotic cell s of the immune system, 
we and others [10,16] suggest that terminal differentiation of cells 
in renewing tissues is a specia lized form of apoptosis. Both share 
ini tial pathways that diverge to allow for fu nctional specification of 
diffe rentiated cell s and again merge at the endpoint. 
Finally, the cellular and molecular basis of some skin diseases can 
be viewed in a different context w hen apoptosis is emphasized. For 
example, apoptosis may playa role in psoriasis, traditionally ap-
proached as a hyperproliferative disorder [59]. The number of cells 
that undergo DNA synthesis in psoriasis exceeds the number that 
enter mitosis by four to five times, suggesting that there is also a 
high rate of cell death at th e S or G2 phases of the cell cycle in 
psoriatic epidermis [13J. Targeting apoptosis for studies of alopecia, 
induced hormonally, by drugs or irradiation, may be productive 
because apoptosis occurs normally in the catagen phase of the hair 
cycle and apoptosis is modulated by these same factors . N ew ave-
nues of research and treatment also are opened by the recognition 
that aberrations in the control of apoptosis may contribute to onco-
genesis. For example, identification of mutations of p53 in skin 
tumors indicates possible unexplored regulatory pathways in skin 
carcinogenesis. A role of cell death in carcinogenesis also is proposed 
in the " two-signal" model [21,22]' suggesting that c-Myc can pro-
vide th e first signa l leading either to apoptosis or proliferation. 
Acquisition of constitutive bcl-2 expression (second signal) pro-
motes survival of affected cells and continued proliferation, increas-
ing the chance for acquiring new mutations or fixation of an already 
mutated oncogene and finally resulting in carcinogenic evolution. 
Unders tandin g the mechanisms that regulate apoptosis and identi-
fying individual control points of the apoptotic pathway will un-
doubtedly have impact on future strategies for therapeutic interven-
tion in treating skin disease . 
REFERENCES 
1. Kerr JFR, Harmon BV: Defini tion and incidence of apoptosis: an historical per-
spective. In: Tomei lD, Cope FO (cds.). Apoptosis: The Molewlar Basis oJCell 
Deatlr. Ctlrrellt COlllllltl llicaliolls ill Cell alld Molewlar Biology. Cold Spring Harbor 
Laboratory Press, Co ld Spring Harbor, NY, 199 1 
2. Glticksmann A: Cell deaths in normal vertebrate ontogeny. BioI Rev 26:59-86, 
195 1 
t Haake RA, Polakowska RR. Ultraviolet Lig ht-induced Programmed 
Cell Death (Apoptosis) in Skin Equivalents. J Invest Dermatol 100: 598A, 
1993 
APOPTOSIS AND THE EPIDERMIS 111 
3. Kerr JFR: A histochemical study of hyperrrophy and ischaemic injury of rat liver 
with special reference to changes in Iysosomes.] Palhol BaCierio190:419 - 435, 
1965 
4. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with 
wide-ranging implications in tissue kinetics. Br] Callcer 26:239 -257. 1972 
5. Lockshin RA, Za keri Z: Programmed cell death and apoptosis. In: Tomei lD, 
Cope FO (cds.). Al'0plosis: The Molewlar Basis oJCell Dealh . CII rrell I Comllllllliea-
tiOIlS ill Cell alld MoleCIIlar Biology. Cold Spring Harbor Laboratory Press, Cold 
Spring Harbor, NY, 199 1 
6. Koseki C. Herzlinger D. AI-Awqati Q: Apoptosis in metanephric development.] 
Cell BioI 11 9: 1327 - 1333, 1992 
7. Sanford ML, Searle JW, Kerr JFR: Successive waves of apoptosis in the rat prostate 
after repeated withdrawal of testosterone stimulation. Palhology 16:406 - 4 to, 
1984 
8. Duke RC: Apoptosis in cel l-mediated immunity. In: Tomei LD, Cope FO (cds.). 
Al'oplosis: The MoleCII/ar Basis oj Cell Death. Cllrrell l Calli mil II ieatiolls ill Cell olld 
Molecular Biology. Cold Spring Harbor Laboratory Press, Cold Spri ng Harbor. 
NY, 1991 
9. Weedon D. Apoptosis. Adll Dermalo/5 :243-256, 1990 
10. Fcsus, L, Davies PJA, Piacentini M: Apoptosis: molecular mechanisms in pro-
grammed cell death. Ellr] Cell BioI 56: 170- 177, 1991 
11. Wyllie AH: Glucocorricoid-induced thymocyte apoptosis is associated with en-
dogenous endonuclease activation. Naillre 284:555-556, 1980 
12. Kanerva L: Electron microscopic observations of dyskeratosis, apoptosis, colloid 
bodies and fibrillar degeneration after skin irritation with dithranol.] Clliall 
Palho/17:37 - 44,1990 
13. Budtz PE: Tisslle Ki,telic Homeoslasis: SllIdies Oil load epidermis. August Krogh Publi-
cations. Copenhagen, 199 1 
14. Young A. The sunburn cel l. Pholodermalolog)' 4:127-134,1987 
15. Grubauer G, Romani N , Kofler H, Staml U , Fritsch P, Hintner H: Apoptotic 
keratin bodies as autoantigcn causing the production ofIgM-anti-kccatin inter-
mediate filament autoantibodies.] h, IIesl Dermalo/87:466 - 471, 1986 
16. Alison MR, Sarraf CE: Apoptosis: a gene-directed programme of cell death. R Call 
Phys LOlldoll 26:25-35, 1992 
17. Duke RC, C hervenak R, Cohen JJ : Endogenous endonuclease-induced DNA 
fragmentation: an early event in cell -mediated cytolysis. ProeNat! Acad Sci USA 
80:6361 - 6365, 1983 
18. Driscoll M: Molecular genetics of cell death in the nematode Caellorhabdiris cle-
ga lls.] Nellrobio/23: 1327 - 1351, 1992 
19. Hengartner M,Ellis R, Horvitz HR: Caellorhabdiliselegaus gene ced-9 protecrs cells 
fro m programmed cell dcath. Nalllre 356:494 - 499, 1992 
20. Vaux DL, Cory S, Adams JM. bcl-2 gene promotes haemopoietic cell survival and 
cooperates with c-myc to immorralize pre-B cells. Nalllre 335:440 - 442, 1988 
21. Bissonnette RP, Echeverri F, Mahboubi A, Green DR: Apoptotic cell death in-
duced by c-myc is inh ibited by bcl-2. Naillre 359:552 - 554, 1992 
22. Fanidi A, Harrington EA, Evan G1: Cooperative interaction berwen c-myc and 
bcl-2 proto-oncogenes. Nalllre 359:554-556, 1992 
23. Siegel R, Karsumata M, Miyashita T, Louie DC, Greene MI, ReedJ C: Inhibition 
of thymocyte apoptosis and negative antige nic selection in bcl-2 transgenic 
mice. Proe Na tl Aead Sci USA 89:7003 - 7007, 1992 
24. Vaux DL, Weissman Il. Kim SK: Prevention of programmed cell death in Caell-
orhabdilis e1egalls by human bcl-2. Science 258: 1955 - 1957, 1992 
25. Sen S: Programmed cell death: concept, mechanism and control. Bioi Rell 
67:287-319,1992 
26. Laster SM, Wood JD, Gooding lR: Tumor necrosis factor can induce both 
apoptosis and necrotic forms of cell lys is.] Immllllol 141 :2629 - 2634, 1988 
27 . Rotello ItJ, lieberman, RC, Purchio AF, Gerschenson LE: Coordinated regula-
tion of apoptosis and cell proliferation by TGF-p1 in cu lrured cell s. Proc Nat! 
Aeod Sci USA 88:3412-3415,1991 
28. Jensen LM, Zhang Y, Shooter E: Steady-srare polypeptide modulations associated 
with nerve growth factor (NGF)-induced terminal differentiation and NGF 
deprivation-induced apoptosis in human neuroblasroma cells.] BioI Chelll 
267: 19325 - 19333, 1992 
29. Williams GT, Smith CA, Spooncer E, Dexter TM. Taylor DR: Haemopoietic 
colony simulating factors promote cell survival by suppressing apoptosis. Na-
IlIr. 343:76- 79, 1990 
30. Barry M, Eastman A: Endonuclease activation during apoptosis: the role of cyto-
solic Ca2+ and pH. Biochem Bi0l'h)'s Res Comm,,,, 186:782- 789, 1992 
31. Tomei LD, Ka nter P, Wenner CE: Inhibi tion of radiation-induced apoptosis ill 
vilro by rumour promoters. Biocl"111 Bioph)'s Res Comm,,,, 115:324-331 , 1981 
32. Marri n S, Cotter T: Ulrraviolet B irradiation of human leukaemia HL-60 cells ill 
IIilro induces apoptosis. IntJ Rad Bioi 59:1001- 1016, 1991 
33. Danno K, Horio T: Formation of UV -i nduced apoptosis relates to the cell cycle. 
Br] Dennolo/107: 423-428, 1982 
34. Vrdoljak E, Bill CA, Stephens LC, Van Der Kogel AJ, Ang KK, Tofilon PJ: 
Radiation-induced apoptosis of oligodendrocytes ill vilro. 1111] Rad BioI 
62:475-480, 1992 
35. Rice WG, Hillyer CD, Harren B, Schaeffer CA, Dorl1liny M, Lackey DA, Kirsten 
E, Mcndeleycv J. Bub KG, Hak:tm A, Kun E: Induction of endonuclease-me-
diated apoptosis in rumor cells by C-ni troso-substituted ligands of po ly (ADP-
ribose)polymerase. Proc Nail Acad Sci USA 89:7703 - 7707, 1992 
36. Dhein J , Daniel PT, Trauth BC. Oehm A, Moller P, Krammer PH: Induction of 
apoptosis by monoclo nal antibody anti-Apo- l class switch variants is dependent 
on cross-linking of APO-1 cell surface antigens.] 1111111'1110/149:3 166-3173 , 
1992 
37. Bursch W, Oberhammer F, Schulte-Hermann R: Cell death by apoptosis and irs 
protective role against disease. Tw,ds PllOrmoeo/ Sci 13:245-251, 1992 
38. Dolle p. Ruberte E, Kastner P, Perkovich M, Stoller CM, Gudas LJ, C hambon P: 
112 HAAKE AND POLAKOWSKA 
Differential expression of genes encoding cx..P,y rctinoic acid receptors and 
CRABP in the developing limbs of the mouse. Nature 342:702 - 705, 1989 
39. Alles AJG, Sulik KK: Perturbation of zones of programmed cell death as a patho-
genetic mechanism. Teratology 40: 163 - 171, 1989 
40. Arends MJ, Morris RG, Wyllie AH: Apoptosis: the role of the endonuclease. Am] 
Path. 136:593 - 608, 1990 
41. McCall CA, Cohen JJ: Programmed cell death in terminally differentiating kera-
tinocytes: role of endogenous endonuclease. ] 11111"'1 Dm'Jatol 97:11 1- 11 4, 
1991 
42. Ucker DS, Obermiller PS, Eckhart W, Apgar JR, Berger NA, Meyers J : Genome 
digestion is a dispensable consequence of physiological cel l death mediated by 
cytotox ic lymphocytes. Mol Cell Bioi 12:3060-3069, 1992 
43. Gavriel i Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death 
in situ via specific labeling of nuclear DNA fragmentation.] Cell Bioi 1 19:493-
501,1 992 
44. Colombel M, Olsson CA, Ng PY, Buttyan R: Hormone-regulated apoptosis 
results from the reentry of differentiated prostrate cell onto a defective cell 
cycle. Call Res 52:4313-4319,1992 
45. Colotta F, Polentarutti N, Sironi M, Mantovani A: Expression and involvement of 
c-fos and c-jun protooncogenes in programmed cell death induced by growth 
factor deprivation in lymphoid cell lines.] Bioi ClwlI 267: 1 8278 - 18283,1992 
46. Lane DP: p53, guardian of the genome. Nature 358:15-16, 1992 
47 . Raff MC: Social controls on cell survival and cell death. Natllre 356:397-399, 
1992 
48. Hockenbery D, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL2 protein is 
topographically restricted in tissues characterized by apoptotic cell death. Prot 
Natl Acad Sci 88:6961-6965,1991 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
49. McConkey DJ, Orrenius S, Jondal M: Ce llular signalling in programmed cell 
death (apoptosis). ]mmllllol Today 11 :120- 121, 1990 
50. Evan G, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters 
CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc 
protein. Cell 69: 119 - 128, 1992 
51. Yonish-Rouach E, Resnitzky D, LotemJ, Sachs L, Kimchi A, Oren M: Wild-type 
p53 induces apoptosis of myeloid leukaemic cell s that is inhibited by interleu-
kin-6. Natllre 352:345-347,1991 
52. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, 
Ponten J: A role for sunli ght in skin cancer: UV -induced p53 mutations in 
squamous cell carcinoma. Prot Natl Acad Sci USA 88: 10124-10128, 1991 
53. Hubbert NL, Sedman SA, Schiller JT: Human papillomavirus type 16 E6 in-
creases the degradation rate of p53 in human keratinocytes.] ViroI66:6237-
624 1,1992 
54. Owens GP, Hahn WE, Cohen JJ: Identification of mRNAs associated with 
programmed cel l death in immature thymocytes. Mol Cell Bioi 11:4177 -4188, 
1991 
55. Munger K, Pietenpol JA, Pittclkow MR, Holt JT, Moses HL: Transforming 
growth factor PI regulation of c-myc expression, pRB phosphorylation, and 
cell cycle progression in keratinocytes. Cdl Growth Dijferelll 3:291 - 298, 1992 
56. Choi Y, Fuchs E: TGFp and retinoic acid :regulators of growth and modifiers of 
differentiation in human epidermal cells. Cell ReglllatiOll 1:791 -809, 1990 
57. Polakowska RR, Goldsmith LA: The cell envelope and transglutaminases. In: 
Goldsmith LA (ed.). Physiology, Biochemistry, alld Mole", /ar Biology oj tl" Skill, 
211d ed. Oxford University Press, Oxford, 1991, pp 168 -201 
58. Fesus L: Apoptosis. ]mlllllllol Today 13:A I6 - AI7, 1992 
59. Goldsmith L: Toads and Psoriasis. Arch Derlll 122:939-940, 1986 
MEETING ANNOUNCEMENTS 
The 8th Annual Dia logues in Cosmetic Dermatology will be held at the LeMeridien Resort 
San Diego, Coronado, California, Wednesday, October 27 to Sunday, October 31, 1993, 
sponsored by Northwestern University Medical School. Co-directors are J.B . Pinski, M.D., and 
Henry H. RoenigkJr. , M.D. Telephone, (312) 263-4625. 
The Sixth International Psoriasis Symposium will be held at the Sheraton Chicago City 
Center Towers, Wednesday, July 20 to Sunday, July 24, 1994, sponsored by Northwestern 
University Medical School. Co-directors are Henry H. Roenigk Jr., M.D., and Howard Mai-
bach, M.D. 
The 18th Annual Hawaii Dermatology Pre-Seminar Business Meeting, Financial Planning, 
Coding, Medicare wi ll be held February 17 - 19, 1994 at the Hyatt Wailea Resort, Maui, HI, 
sponsored by Northwestern University Medical School. Co-directors are Henry H. Roenigk 
Jr., M.D., and Howard Maibach, M.D. Telephone, (312) 908-8173; FAX, (312) 908-0664. 
The 18th Annual Hawaii Dermatology Seminar will be held February 19 - 23, 1994 at the 
Hyatt Wailea Resort, Maui, HI, sponsored by Northwestern University Medical School. Co-
directors are Henry H. Roenigk Jr., M.D., and Howard Maibach, M.D. Telephone, (312) 
908-8173; FAX, (312) 908-0664. 
The 18th Annual Hawaii Dermatology Post-Seminar will be held February 23 - 26, 1994 at 
the Ritz Carlton Mauna Lanai, Big Island, Hawaii, sponsored by Northwestern University 
Medical School. Co-directors are Henry H. Roenigk Jr., M.D., and Howard Maibach, M.D. 
Telephone, (312) 908-8173; FAX, (312) 908-0664. 
The 2nd International Symposium on Cutaneous T-Cell Lymphoma will be held Wednes-
day, October 13 to Saturday, October 16, 1993 at the Northwestern University Medical 
School, Chicago, IL. Co-directors are Henry H. RoenigkJr., M.D., Steven Rosen, M.D., and 
Timothy Kuzel , M.D. 
